摘要
目的评价超声支气管镜引导下的经支气管针吸活检（endobronchialultrasound—guidedtransbronchialneedleaspiration，EBUS-TBNA）在纵隔淋巴结定性诊断中的价值。方法对2011年8月至2013年2月胸部CT诊断的148例纵隔淋巴结患者行EBUS-TBNA，回顾性分析和总结其中外科手术或胸腔镜纵隔镜病理确诊为淋巴结恶性肿瘤的129例EBUS-TBNA结果，评价该技术的优势、穿刺成功率及诊断准确率。结果实施EBUS-TBNA的129例患者纵隔淋巴结在扫描和活检中均能清晰显示、准确引导，118例取得阳性诊断，11例假阴性，穿刺成功率100％，诊断正确性91．47％，无并发症发生。结论EBUS_TBNA是确诊纵隔淋巴结病变和评价新辅助化疗疗效的安全、实用的技术。
Objective To evaluate the diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration （EBUS-TBNA） in the diagnosis of mediastinal lymphadenopathy. Methods EBUS-TBNA were performed in 148 mediastinal lymphadenopathy previously by CT were selected,and 129 malignant tumor were confirmed by surgery. The advantages of EBUS-TBNA were evaluated, including superiority, success rate of puncture and diagnostic accurary. Results In 129 cases, mediastinal lymphadenopathy were detected clearly and were guided accurately by EBUS-TBNA. The positive results were obtained in 118 cases, and the false negative results in 11 cases. The success rate of biopsy and sensitivity of diagnosis by EBUS-TBNA in malignant tumor were 100% and 91.47% respectively. There were no complications in this group. Conclusions EBUS-TBNA is a safe and useful technique in diagnosis of mediastinal lymphadenopathy and evaluate the response to neoadjuvant chemotherapy.
出处
《中华超声影像学杂志》
CSCD
北大核心
2013年第11期954-956,共3页
Chinese Journal of Ultrasonography
基金
国家自然科学基金（81201830）
